8-K: Mosaic's 2025 Mixed Bag: Full-Year Profit, Q4 Loss

The Mosaic Company reported a full-year 2025 net income of $541 million but a fourth-quarter net loss of $519 million, significantly impacted by notable impairment charges and weak U.S. demand.

Summary

• Full year 2025 net income was $541 million, with diluted earnings per share (EPS) of $1.70.
• Full year 2025 adjusted EBITDA totaled $2.4 billion, and adjusted diluted EPS was $2.27.
• The company reported a fourth quarter net loss of $519 million, resulting in diluted EPS of $(1.64).
• Fourth quarter adjusted EBITDA was $505 million, with adjusted diluted EPS of $0.22.
• The fourth quarter net loss included $422 million in pre-tax notable items, such as a $189 million impairment for the Carlsbad asset and $110 million in goodwill and fixed asset impairments in Mosaic Fertilizantes.
• Fourth quarter earnings were also negatively impacted by a $261 million after-tax reserve on deferred tax assets in Mosaic Fertilizantes.
• Adjusted EBITDA in 2025 increased by 10% from 2024, driven by higher prices and sales volumes in the Potash segment, margin expansion in Mosaic Fertilizantes, and improved margins in India and China.
• Cash flow from operations for 2025 was $825 million, down from $1.3 billion in 2024, primarily due to higher balance sheet working capital and increased finished product inventories.
• Capital expenditures for 2025 were $1.36 billion, an increase from $1.25 billion in 2024, mainly for phosphate asset health and production reliability.
• Free cash flow was negative $(535) million in 2025, compared to positive $47 million in 2024.
• The company returned $280 million to shareholders through dividends in 2025, including a regular common dividend of $0.22 per share in the fourth quarter.
• Potash segment net sales increased to $2.7 billion in 2025, with operating earnings of $638 million and adjusted EBITDA of $1.2 billion.
• Phosphate segment net sales were $4.6 billion in 2025, but operating earnings declined to $135 million and adjusted EBITDA to $917 million.
• Mosaic Fertilizantes reported net sales of $4.8 billion in 2025, with operating earnings of $277 million and adjusted EBITDA of $567 million.
• Mosaic Biosciences' net sales more than doubled to $68 million in 2025 and contributed positively to fourth quarter adjusted EBITDA.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mixed report with strong full-year adjusted EBITDA growth overshadowed by a significant Q4 net loss driven by impairments and a negative free cash flow, indicating underlying operational challenges despite some positive segment performances and a constructive market outlook.

Positives

• Full year 2025 net income of $541 million and adjusted EBITDA of $2.4 billion, representing a 10% increase from 2024.
• Potash segment demonstrated strong performance in 2025 with net sales up to $2.7 billion, operating earnings up to $638 million, and adjusted EBITDA up to $1.2 billion, driven by higher prices and sales volumes.
• Potash production volumes reached 8.8 million tonnes in 2025, with MOP output at its highest level since 2019, and Belle Plaine setting a new production record.
• Mosaic Fertilizantes operating earnings increased 16% to $277 million and adjusted EBITDA increased 65% to $567 million in 2025.
• Mosaic Biosciences' net sales more than doubled to $68 million in 2025 and positively contributed to fourth quarter adjusted EBITDA.
• The company achieved its $150 million value capture target in 2025 and expanded the program to target an additional $100 million in 2026.
• Asset sales announced in 2025 are expected to yield approximately $230 million in total consideration, including $170 million in cash payments and a $60 million reduction of asset retirement obligations (ARO).
• Fourth quarter phosphate production totaled 1.7 million tonnes, with improved performance continuing into early 2026, and 2026 production volumes expected at or above 7.0 million tonnes.
• Work on the Faustina ammonia plant is expected to support an over 50% increase in ammonia production in 2026, enhancing Mosaic's cost position and competitiveness.
• The agriculture market outlook is generally stable, with expectations for another sizable Brazilian soybean crop and a shift toward corn acreage in North America, supporting fertilizer demand.
• Plant nutrient markets are poised for a more constructive 2026, with momentum building for spring application seasons globally, and prices already responding positively to global demand.
• China's extended phosphate export restrictions are tightening phosphate markets, leading to demand inquiries from destinations historically served by Chinese suppliers, which benefits Mosaic.

Negatives

• Fourth quarter 2025 resulted in a net loss of $519 million and diluted EPS of $(1.64), a significant decline from prior periods.
• Fourth quarter adjusted EBITDA of $505 million was negatively impacted by weak U.S. demand.
• The Q4 net loss was heavily influenced by $422 million in pre-tax notable items, including a $189 million impairment related to the Carlsbad asset held for sale and $110 million in goodwill and fixed asset impairments in Mosaic Fertilizantes.
• A $261 million after-tax reserve on deferred tax assets in Mosaic Fertilizantes further negatively impacted Q4 earnings.
• Cash flow from operations declined to $825 million in 2025 from $1.3 billion in 2024, with Q4 cash flow from operations being negative $(56) million due to an accelerated inventory build.
• Free cash flow was negative $(535) million in 2025, a substantial decrease from positive $47 million in 2024.
• The Phosphate segment experienced a decline in operating earnings to $135 million and adjusted EBITDA to $917 million in 2025, attributed to lower sales volumes, higher cash cost of conversion, and increased idle and turnaround expenses.
• Lower U.S. phosphate demand amid affordability challenges in Q4 led to finished product inventories above prior periods.
• Mosaic Fertilizantes recorded an operating loss of $26 million in Q4, with reduced adjusted EBITDA, due to a goodwill impairment, lower sales volumes, reduced distribution margin, and higher sulfur costs.
• Temporary curtailment of SSP production at the Fospar JV and Araxa site (approximately 30% of Mosaic's Brazil production) was implemented due to a sharp increase in sulfur prices.
• First quarter 2026 sales volumes for Mosaic Fertilizantes are expected to be below prior year levels due to ongoing credit challenges and SSP production curtailment.
• Selling, general and administrative (SG&A) expenses increased to $534 million for full year 2025, up from $497 million in 2024.

Risks

• Deferred demand and higher raw material costs negatively impacted year-end results.
• Weak U.S. phosphate demand amid affordability challenges led to elevated finished product inventories.
• Benchmark sulfur prices rose above $500 per tonne late in the fourth quarter, with the full impact expected in cost of goods sold in the second quarter of 2026, potentially reducing quarterly EBITDA by approximately $10 million for every $10 per tonne increase.
• Intensified competition and tightening credit conditions in Brazil impacted fourth quarter sales volumes and distribution margin per tonne for Mosaic Fertilizantes.
• A sharp increase in sulfur prices, absent mitigating actions, could materially impact production margins in Mosaic Fertilizantes in 2026.
• Ongoing credit challenges in Brazil are expected to keep first quarter 2026 sales volumes below prior year levels for Mosaic Fertilizantes.
• Forward-looking statements are subject to significant risks and uncertainties including political and economic instability, volatility of agriculture, fertilizer, raw material, energy, and transportation markets, inventory levels in distribution channels, effects of future product innovations, changes in foreign currency and exchange rates, international trade risks (including tariffs), material adverse changes in the Ma'aden investment, customer defaults, changes in government policy, changes in environmental and other governmental regulation (e.g., carbon taxes, water quality standards), further developments in judicial or administrative proceedings, difficulties or delays in receiving governmental permits or approvals, increased financial assurance requirements, resolution of global tax audit activity, effectiveness of strategic priorities, adverse weather conditions, actual costs differing from management's estimates (e.g., asset retirement, environmental remediation, Canadian resources taxes), brine inflows at potash mines, other accidents and disruptions, and cybersecurity risks.

Future Outlook

Demand is expected to recover as the company moves toward the planting season. First quarter phosphate sales volumes are projected to recover sequentially to 1.7 to 1.9 million tonnes, with DAP prices averaging $640 to $670 per tonne. Total potash production in 2026 is expected to be approximately 9 million tonnes, supported by record production at Esterhazy. First quarter 2026 potash sales volumes are anticipated to be between 2.0 and 2.2 million tonnes, with MOP prices ranging from $255 to $275 per tonne. Phosphate production volumes for 2026 are expected to be at or above 7.0 million tonnes. Capital expenditures for 2026 are estimated at approximately $1.5 billion, with ARO and environmental reserves spending expected to decline to around $350 million. Mosaic Biosciences plans to launch eight to ten new products in 2026 and targets doubling its net sales again. The agricultural market outlook is generally stable, with expectations for a sizable Brazilian soybean crop and a shift toward corn acreage in North America, supporting fertilizer demand. Global plant nutrient markets are expected to be more constructive in 2026, with China's extended phosphate export restrictions tightening markets and global potash shipments potentially reaching record levels. However, first quarter Mosaic Fertilizantes sales volumes, distribution margins, and production margins are expected to be below prior year levels due to ongoing credit challenges and SSP production curtailment, with segment adjusted EBITDA projected to be below $50 million.

Management Comments

• "Mosaic made significant progress in 2025. We fortified our assets to ensure reliable production, delivered meaningful cost and efficiency progress and divested non-core assets."
• "Deferred demand and higher raw material costs negatively impacted our year end results, but demand is expected to recover as we move toward the planting season."

Industry Context

StockSavvy.ai notes that the agricultural market outlook remains generally stable, with expectations for strong crop yields and acreage shifts supporting fertilizer demand. The tightening of phosphate markets due to China's export restrictions presents a favorable environment for Mosaic, while balanced potash markets and potential record global shipments also indicate positive industry trends. However, regional challenges like credit constraints in Brazil and volatile sulfur prices introduce headwinds that could impact profitability for industry players.

Comparison to Industry Standards

• Mosaic's 10% increase in full-year 2025 adjusted EBITDA, driven by strong Potash and Mosaic Fertilizantes segments, suggests robust performance in specific areas. This can be benchmarked against peers like Nutrien Ltd. (NTR) or CF Industries Holdings, Inc. (CF), whose overall results are influenced by their diverse product mixes and regional exposures.
• The record MOP output since 2019 and record Belle Plaine production in Mosaic's Potash segment highlight operational excellence and efficiency. This level of production capability is a key competitive advantage, potentially allowing for lower unit costs compared to smaller, less integrated potash producers or those with older mining infrastructure.
• The negative free cash flow of $(535) million in 2025, primarily due to increased working capital and inventory build, indicates a divergence from companies that prioritize consistent positive cash generation, especially in volatile commodity markets. This could be a point of concern when compared to companies with more stable cash flow profiles, reflecting different capital allocation strategies or market exposures.
• The significant Q4 impairment charges, including $189 million for the Carlsbad asset and $110 million for goodwill/fixed assets in Mosaic Fertilizantes, reflect specific asset valuation challenges. While impairments are not uncommon in the industry, the magnitude here suggests a need for asset rationalization or a re-evaluation of certain regional strategies, which might be more pronounced than for peers with a more stable asset base or different geographic focus.
• The temporary curtailment of SSP production in Brazil due to high sulfur costs demonstrates a reactive measure to input price volatility. This is a common industry challenge, but the extent of the curtailment (30% of Brazil production) indicates a material impact, potentially more severe than for competitors with more diversified raw material sourcing or stronger hedging strategies.

Stakeholder Impact

• Shareholders are impacted by the significant Q4 net loss and negative free cash flow, but also by the continued dividend payments ($280 million in 2025) and positive full-year adjusted EBITDA. Future performance will depend on demand recovery and effective cost management.
• Employees at Esterhazy were affected by a temporary idling of operations due to a previously reported fatality in early December. Employees in Brazil may be impacted by the temporary curtailment of SSP production due to high sulfur costs.
• Customers in the U.S. faced weak phosphate demand amid affordability challenges, leading to higher inventories. Customers in Brazil are experiencing tightening credit conditions. However, global demand is expected to recover for upcoming spring planting seasons.
• Suppliers of raw materials, particularly sulfur, are impacting Mosaic's cost of goods sold and production decisions, as evidenced by the temporary curtailment of SSP production.
• Creditors may note the negative free cash flow and increased capital expenditures, although asset sales are expected to provide cash payments and reduce asset retirement obligations.

Next Steps

• Demand is expected to recover as the company moves toward the planting season.
• First quarter 2026 phosphate sales volumes are expected to recover sequentially to 1.7 to 1.9 million tonnes.
• First quarter 2026 potash sales volumes are expected to be in the range of 2.0 and 2.2 million tonnes.
• Mosaic Biosciences expects to launch eight to ten new products in 2026 and targets net sales to approximately double compared with 2025.
• Mosaic continues to assess production plans for SSP as sulfur market conditions evolve.
• A conference call will be held on February 25, 2026, at 11:00 a.m. Eastern Time to discuss fourth quarter and full year 2025 earnings results.

Key Dates

Recommendation

While full-year adjusted EBITDA showed growth and the company has a positive outlook for 2026 demand and production, the significant Q4 net loss driven by substantial impairments, negative free cash flow, and ongoing regional challenges (e.g., Brazil credit, sulfur costs) introduce considerable uncertainty. The stock may experience volatility in the short term, warranting a hold position until clearer signs of sustained operational improvement and demand recovery materialize, especially given the forward-looking guidance for Q1 2026 in Mosaic Fertilizantes.

Keywords

Fertilizer, Potash, Phosphate, Agriculture, Crop Nutrients, Mosaic Company, MOS, Earnings, Financial Results, SEC Filing, 8-K, Adjusted EBITDA, Net Income, Brazil, Biosciences, Sulfur, Impairment, Cash Flow